News
Leukemic breast tumors may cause resistance in AML, ALL
Isabel Cunningham, MD, of Columbia University in New York, has found evidence to suggest that treatment resistance in leukemia patients may...
News
Embedded miRNA, not its host, drives AML, group says
Credit: Lance Liotta A small gene embedded in a larger gene appears to be the driving force behind acute myeloid leukemia (AML) development,...
News
FDA proposes new program for medical devices
device responds to stress Credit: FDA The US Food and Drug Administration (FDA) is proposing a new program to provide patients with earlier...
News
Protein helps HSP90 inhibitors fight cancers
Credit: PNAS Researchers have discovered how a molecule called CUL5 helps HSP90 inhibitors kill cancer cells, according to a study published in...
Article
Keep an eye on the HPV p16 protein in head and neck cancer
At the 2014 Multidisciplinary Head and Neck Cancer Symposium in Scottsdale, Arizona, experts presented their findings on novel therapies and...
Article
The late effects of cancer and cancer treatment: a rapid review
This paper aims to synthesize literature about the definition, prevalence, onset and treatments associated with late effects. A rapid review was...
News
Pinterest as a marketing tool
News
Hereditary cancer syndromes
News
Team identifies potential treatment for FLT3-ITD AML
Credit: Eric Smith Researchers have presented evidence to support the use of a BET protein antagonist in FLT3-ITD-mutated acute myeloid leukemia...
News
Drug gets orphan designation for AML
Credit: NIH The US Food and Drug Administration and the European Commission have granted volasertib orphan designation for the treatment of acute...